130
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue

, , , , , , , , & show all
Pages 5819-5835 | Published online: 18 Sep 2015

References

  • BestBMLetendreSLBrigidECHARTER GroupLow atazanavir concentrations in cerebrospinal fluidAIDS2009231838719050389
  • DingHWuFNairMPImage-guided drug delivery to the brain using nanotechnologyDrug Discov Today20131821–221074108023817076
  • DaneKYNembriniCTomeiAANano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survivalJ Control Release2011156215416021864593
  • KanmogneGDSinghSRoyUMononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cellsInt J Nanomedicine201272373238822661891
  • LernerPGuadalupeMDonovanRThe gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapyJ Virol201185104772478221345945
  • VaratharajanLThomasSAThe transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further researchAntiviral Res2009822A99A10919176219
  • Pilakka-KanthikeelSAtluriVSSagarVSaxenaSKNairMTargeted brain derived neurotropic factors (BDNF) delivery across the blood–brain barrier for neuro-protection using magnetic nano carriers: an in-vitro studyPLoS One201384e6224123653680
  • RoyUBulotCHoner zu BentrupKMondalDSpecific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavirPLoS One2013810e7537424098380
  • HondoTKanayaTTakakuraICytokeratin 18 is a specific marker of bovine intestinal M cellAm J Physiol Gastrointest Liver Physiol20113003G442G45321193527
  • KerneisSBogdanovaAKraehenbuhlJ-PPringaultEConversion by Peyer’s patch lymphocytes of human enterocytes into M cells that transport bacteriaScience199727753289499529252325
  • GullbergELeonardMKarlssonJExpression of specific markers and particle transport in a new human intestinal M-cell modelBiochem Biophys Res Commun2000279380881311162433
  • ManochaMPalPCChitralekhaKTEnhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell targetVaccine20052348–495599561716099080
  • des RieuxARagnarssonEGGullbergEPreatVSchneiderYJArturssonPTransport of nanoparticles across an in vitro model of the human intestinal follicle associated epitheliumEur J Pharm Sci2005254–545546515946828
  • DhoroMZvadaSNgaraBCYP2B6*6, CYP2B6*18, body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in ZimbabweBMC Pharmacol Toxicol201516425889207
  • OlagunjuABolajiOAmaraABreast milk pharmacokinetics of efavirenz and breastfed infants’ exposure in genetically-defined subgroups of mother-infant pairs: an observational studyClin Infect Dis201561345346325882300
  • MartínASGómezAIGarcía-BerrocalBDose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogeneticsPharmacogenomics2014157997100624956253
  • DingHYongK-TLawW-CNon-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibodyNanoscale2011341813182221365120
  • DingHYongK-TRoyIBioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriersNanotechnology2011221616510121393821
  • DingHSagarVAgudeloMEnhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulationNanotechnology201425505510110.1088/0957-4484/25/5/055101(5)24406534
  • GandhiNSaiyedZMNapuriJInteractive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood–brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorderJ Neurovirol201016429430520624003
  • WuFBhansaliSGTamhaneMNoninvasive real-time fluorescence imaging of the lymphatic uptake of BSA-IRDye 680 conjugate administered subcutaneously in miceJ Pharm Sci201210151744175422262501
  • AgudeloMGandhiNSaiyedZEffects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA)Alcohol Clin Exp Res20113581550155621447001
  • SchmidtmayerovaHAlfanoMNuovoGBukrinskyMHuman immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a post entry levelJ Virol1998726463346429573226
  • AtluriVSKanthikeelSPReddyPVYndartANairMPHuman synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND)PLoS One201384e6139923620748
  • AtluriVSPilakka-KanthikeelSSamikkannuTVorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorderMol Brain201473724886748
  • YangSPLiuWCLeeKYEffectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoringJ Int AIDS Soc2014174 Suppl 31952425394033
  • HurstSJEiflerAThaxtonCSNanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case studyMethods Mol Biol201172632533821424459
  • ElluruMMaHHadjiargyrouMHsiaoBSChuBSynthesis and characterization of biocompatible hydrogel using Pluronics-based block copolymersPolymer201354820882095
  • SimonTBocaSBiroDBaldeckPAstileanSGold-Pluronic core-shell nanoparticles: synthesis, characterization and biological evaluationJ Nanopart Res201315418
  • ChenLShaXJiangXChenYRenQFangXPluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluationInt J Nanomedicine20138738423319859
  • OerlemansCBultWBosMStormGNijsenJFHenninkWPolymeric micelles in anticancer therapy: targeting, imaging and triggered releasePharm Res201027122569258920725771
  • HaseKKawanoKNochiTUptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune responseNature2009462727022623019907495
  • KunisawaJKurashimaYKiyonoHGut-associated lymphoid tissues for the development of oral vaccinesAdv Drug Deliv Rev201264652353021827802
  • WallaceSJLiJNationRLBoydBJDrug release from nanomedicines: selection of appropriate encapsulation and release methodologyDrug Deliv Transl Res20122428429223110256
  • HuaSComparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug deliveryInt J Nanomedicine2014973574424511230
  • DuBLiYLiXYoumeiAChenCZhangZPreparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomesInt J Pharm20103841–214014719800955
  • LiSHuJZhangLIn-vitro and in-vivo evaluation of austocystin D liposomesJ Pharm Pharmacol201365335536223356844
  • ReddySTRehorASchmoekelHGHubbellJASwartzMAIn vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticlesJ Control Release20061121263416529839
  • DingHWuFImage guided biodistribution and pharmacokinetic studies of theranosticsTheranostics20122111040105323227121
  • DingHWuFImage guided biodistribution of drugs and drug deliveryTheranostics20122111037103923227120
  • TanRNiuMZhaoJLiuYFengNPreparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targetingJ Drug Target201422650951724625287
  • TorchilinVPMultifunctional nanocarriersAdv Drug Deliv Rev200658141532155517092599
  • DingHYongK-TRoyIGold nanorods coated with multilayer polyelectrolyte as contrast agents for multimodal imagingJ Phys Chem C2007111341255212557
  • TahounAMahajanSPaxtonESalmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasionCell Host Microbe201212564565623159054
  • OikonomouEMakrodouliEEvagelidouMJoyceTProbertLPintzasABRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cellsNeoplasia200911111116113119881948
  • HaneyMJSureshPZhaoYBlood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain deliveryNanomedicine (Lond)20127681583322236307
  • YukiYNochiTKiyonoHProgress towards an AIDS mucosal vaccine: an overviewTuberculosis (Edinb)200787suppl 1S35S4417652028